Key result
Non-invasive thoracocardiography-derived peak aortic acceleration strongly correlates with invasive dP/dtmax in rats.
Why the study?
Preclinical studies of cardiac contractility in rodents are limited by the invasiveness of current measurement techniques, prompting investigation into whether non-invasive thoracocardiography can serve as a surrogate for dP/dtmax.
Can non-invasive thoracocardiography (TCG) indices serve as robust surrogates for invasive left ventricular contractility (dP/dtmax) in rats?
Population
Anesthetized rats
Comparison
Thoracocardiography-derived indices vs invasive dP/dtmax reference during pharmacological hemodynamic challenge
Design
Preclinical validation study
Authors
Loading...
May support non-invasive LV contractility monitoring via TCG in rat models; leaves open human validation.
Can non-invasive thoracocardiography (TCG) indices serve as robust surrogates for invasive left ventricular contractility (dP/dtmax) in rats?
Effect estimate: r = 0.83
p-value: p=<0.001
Thoracocardiography-derived peak aortic acceleration provides a robust, non-invasive surrogate for left ventricular contractility (dP/dtmax) in rats.
Fontana-Pires et al. (2026) studied Healthy (preclinical animal model) (n=9). Thoracocardiography (TCG) flow-derived indices vs. Invasive dP/dtmax (Millar catheter) was evaluated on Correlation between TCG-derived peak aortic acceleration (Ap) and invasive dP/dtmax (r = 0.83, p=<0.001). Non-invasive thoracocardiography-derived peak aortic acceleration strongly correlated with invasive dP/dtmax (r = 0.83, p < 0.001) during pharmacological hemodynamic challenges in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: